These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8684686)

  • 1. [Human recombinant erythropoietin in the treatment of anemia in obstetric-gynecologic patients. Evaluation of such treatment as an alternative to blood transfusion].
    Delzanno G; Falcone M; Gaudiano L; Bertinetti G; Demarchi A; Paoletti R
    Minerva Ginecol; 1996 Mar; 48(3):115-8. PubMed ID: 8684686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Human recombinant erythropoietin in the treatment of the severe anemia following labor (a preliminary report)].
    Malinova M
    Akush Ginekol (Sofiia); 1999; 38(4):13-5. PubMed ID: 10726343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a combined therapy of erythropoietin, iron, folate, and vitamin B12 on the transfusion requirements of extremely low birth weight infants.
    Haiden N; Schwindt J; Cardona F; Berger A; Klebermass K; Wald M; Kohlhauser-Vollmuth C; Jilma B; Pollak A
    Pediatrics; 2006 Nov; 118(5):2004-13. PubMed ID: 17079573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled trial of the effects of adding vitamin B12 and folate to erythropoietin for the treatment of anemia of prematurity.
    Haiden N; Klebermass K; Cardona F; Schwindt J; Berger A; Kohlhauser-Vollmuth C; Jilma B; Pollak A
    Pediatrics; 2006 Jul; 118(1):180-8. PubMed ID: 16818564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human erythropoietin in the treatment of postpartum anemia.
    Huch A; Eichhorn KH; Danko J; Lauener PA; Huch R
    Obstet Gynecol; 1992 Jul; 80(1):127-31. PubMed ID: 1603482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recombinant human erythropoietin in the treatment of anemic patients undergoing chemotherapy for cancer].
    Bösze P; Mayer A; Thurzó L; Kiss A; Rák K; Stumpf J
    Orv Hetil; 1995 Nov; 136(47):2567-72. PubMed ID: 8532322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.
    Henry DH; Brooks BJ; Case DC; Fishkin E; Jacobson R; Keller AM; Kugler J; Moore J; Silver RT; Storniolo AM; Abels RI; Gordon DS; Nelson R; Larholt K; Bryant E; Rudnick S
    Cancer J Sci Am; 1995; 1(4):252-60. PubMed ID: 9166485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
    Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin and intravenous iron therapy in postpartum anaemia.
    Wågström E; Akesson A; Van Rooijen M; Larson B; Bremme K
    Acta Obstet Gynecol Scand; 2007; 86(8):957-62. PubMed ID: 17653881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin and chronic lymphocytic leukemia.
    Mauro FR; Gentile M; Foa R
    Rev Clin Exp Hematol; 2002; Suppl 1():21-31. PubMed ID: 12735212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
    J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension in a pregnancy with renal anemia after recombinant human erythropoietin (rhEPO) therapy.
    Kashiwagi M; Breymann C; Huch R; Huch A
    Arch Gynecol Obstet; 2002 Nov; 267(1):54-6. PubMed ID: 12410378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: a 19-week, phase II, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease.
    Besarab A; Salifu MO; Lunde NM; Bansal V; Fishbane S; Dougherty FC; Beyer U;
    Clin Ther; 2007 Apr; 29(4):626-39. PubMed ID: 17617286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietic response induced by recombinant human erythropoietin in anemic cancer patients candidate to major abdominal surgery.
    Braga M; Gianotti L; Gentilini O; Vignali A; Di Carlo V
    Hepatogastroenterology; 1997; 44(15):685-90. PubMed ID: 9222672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ferro-Folgamma--a drug for treatment and prophylaxis of iron deficiency anemia in pregnant women].
    Bozhinova S; Penkov V; Bogdanova A
    Akush Ginekol (Sofiia); 2004; 43(3):27-31. PubMed ID: 15341253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recombinant human erythropoietin in anemia associated with pediatric cancer: study of the identification of predictors of response].
    León Molinari P; Jiménez Monteagudo M; Barona Zamora P; Riol Diego M; Castro Paz L; Sierrasesúmaga Ariznavarreta L
    An Esp Pediatr; 1998 Jul; 49(1):17-22. PubMed ID: 9718761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of iron deficiency anemia with Ferro-Folgamma.
    Ghinea MM
    Rom J Intern Med; 2004; 42(1):225-30. PubMed ID: 15529613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
    Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
    Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild postnatal anemia: is it a problem?
    Tam KF; Lee CP; Pun TC
    Am J Perinatol; 2005 Oct; 22(7):345-9. PubMed ID: 16215918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.